Patrick Campbell is the assistant managing editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record.  Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Podcasts

A podcast episode featuring a discussion related to racial and ethnic disparities in the care of children with type 1 diabetes.

Addressing Racial Disparities in the Care of Children with Diabetes

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition. 

Raymond Douglas, MD, PhD: Treatment of Thyroid Eye Disease in 2020

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

The Endocrine Outlook: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals. 

Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time. 

The Impact of COVID-19 on Diabetes Research

An endocrinologist offers perspective on his reaction to EMPEROR-REDUCED topline results and what he hopes to see from the full results at ESC 2020. 